Sharpening the dialogue with overseas investors, quarter by quarter.
Not a one-off diagnosis or review, but a retainer that improves the overseas-investor dialogue on a quarterly cycle: English IR review before each results date, meeting preparation and debriefs, continuous disclosure improvement, and a cumulative anticipated-Q&A file — four cycles a year plus ad hoc. Because we retain the company context and equity story, you never re-explain the business from zero.
One loop from diagnosis to meetings
IR diagnosis / diagnosis card
The starting point: current state scored on 12 items / 24 points, priorities on one card.
Internal walkthrough
The card read through with IR, the CFO office, corporate planning, and management so next quarter's priorities are shared.
Equity story design
Investment highlights, growth assumptions, profitability, capital allocation, and competitive advantage organized into one story told the same way everywhere.
Quarterly disclosure improvement
The agreed priorities reflected into the next earnings deck, English disclosure, and IR-site update on the same axis.
Meeting prep & Q&A
The sensitive topics — capital allocation, shareholder returns, growth assumptions, governance — turned into short, answerable Q&A.
Post-meeting review
Investor questions and reactions recorded and fed back into the next disclosure and Q&A update.
What you receive each quarter
- Quarterly IR-readiness report: pre-results English IR check and improvement priorities
- Meeting observation notes: anonymized observations from overseas-investor meetings
- Cumulative anticipated-Q&A updates reflecting past investor reactions
- Monthly 30-minute sync with IR / corporate planning / CFO (1–2 per month)
- Ad hoc consultation during the contract period
Three retainer plans
Initial diagnosis
Diagnosis card (12 items / 24 points), top-3 issues, priority order, 60-minute internal walkthrough. For a first stocktake.
Quarterly disclosure improvement
Initial diagnosis plus quarterly re-scoring, results-material checks, and translation / English review aligned with the findings.
Full IR loop incl. meetings
Everything in Standard plus meeting preparation, in-room interpretation / observation, and post-meeting reaction reports.
Frequently asked questions
Is there a minimum term?
Which companies is this for?
Can we start with a single translation or meeting instead?
Can we take just the diagnosis first?
Discuss ongoing support
Tell us where your English disclosure and meetings stand — we will propose where to start.